Clinical Study Agreement Template for Singapore

A Clinical Study Agreement is a comprehensive legal contract that governs the conduct of clinical trials and biomedical research in Singapore. This document establishes clear roles, responsibilities, and obligations between all parties involved in clinical research, ensuring compliance with Singapore's robust regulatory framework while protecting the rights and safety of research participants.

When do you need this document?

You need a Clinical Study Agreement whenever conducting human biomedical research in Singapore involving pharmaceutical companies, research institutions, hospitals, or contract research organizations. This includes Phase I through IV clinical trials, observational studies, medical device trials, and investigator-initiated research studies. The agreement is mandatory before commencing any research activities involving human subjects in Singapore's healthcare facilities, whether public hospitals like Singapore General Hospital or private medical institutions. You also require this document when establishing partnerships between international sponsors and local Singapore institutions for multi-center trials or when transferring research responsibilities between different parties during a study.

Key legal considerations

Your Clinical Study Agreement must address critical legal elements including detailed study protocol specifications, regulatory compliance obligations, and clear delineation of responsibilities between sponsors, principal investigators, and institutions. The document should establish comprehensive indemnification clauses protecting all parties from liability arising from protocol deviations or adverse events. Intellectual property provisions must clearly define ownership of study data, research results, and any discoveries or inventions arising from the research. Financial arrangements including payment schedules, cost responsibilities, and budget allocations require precise documentation to avoid disputes. The agreement must also include robust confidentiality clauses protecting proprietary information and patient data, along with detailed procedures for data handling, storage, and transfer in compliance with Singapore's Personal Data Protection Act.

Legal requirements in Singapore

Singapore's regulatory framework requires your Clinical Study Agreement to comply with multiple legislative acts including the Human Biomedical Research Act (HBRA), which mandates institutional review board approval and ongoing oversight of research activities. The Medicines Act and associated Clinical Trials Regulations govern pharmaceutical research, requiring Health Sciences Authority approval and compliance with Good Clinical Practice guidelines. Your agreement must incorporate provisions for regular safety reporting, adverse event documentation, and regulatory inspection readiness. The Health Products Act applies to medical device studies, while the Private Hospitals and Medical Clinics Act ensures appropriate standards in private healthcare facilities. Additionally, your agreement must address Singapore's licensing requirements for research personnel, facility standards for clinical trial conduct, and mandatory registration with relevant regulatory authorities before study commencement.